Plain-English translation of NCT06791538 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether robot-assisted gastrectomy (surgical removal of the stomach) is as effective and safer than standard laparoscopic surgery for patients with locally advanced stomach cancer. Researchers want to know if using robotic technology helps patients live longer without cancer returning and recover more safely after surgery.
Doctors are looking for ways to treat advanced stomach cancer more effectively while reducing complications and recovery time. This trial will help determine whether the newer robotic surgical approach offers real benefits over the standard minimally invasive technique that is already in use.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either robot-assisted surgery or standard laparoscopic surgery to remove your stomach. After your procedure, you will have regular follow-up visits at 30 days, 3 months, 6 months, and then every 3 months up to 3 years after surgery. At these visits, you will have blood tests, imaging scans (such as CT scans and X-rays), and physical exams to monitor your recovery and check whether the cancer has returned.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China